Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can an AI app solve epilepsy med problems?

NCT ID NCT07445074

First seen Mar 08, 2026 · Last updated May 24, 2026 · Updated 8 times

Summary

This study tests whether an AI-enhanced version of the Medilepsy® app helps underserved teens and young adults (ages 14-24) with epilepsy take their anti-seizure medication more consistently. The app sends reminders and tracks adherence, and the AI version personalizes these prompts. Researchers will also measure how ready participants are to manage their own health as they transition to adult care. The goal is to improve daily disease control, not to cure epilepsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Orlando Health

    RECRUITING

    Orlando, Florida, 32806, United States

    Contact

  • University of Central Florida

    RECRUITING

    Orlando, Florida, 32827, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.